Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1986 Jan;45(1):37–43. doi: 10.1136/ard.45.1.37

Studies of the effect of D-penicillamine and sodium aurothiomalate therapy on superoxide anion production by monocytes from patients with rheumatoid arthritis: evidence for in vivo stimulation of monocytes.

N P Hurst, A L Bell, G Nuki
PMCID: PMC1001812  PMID: 3006610

Abstract

The capacity of monocytes from patients with rheumatoid arthritis to generate superoxide anion in vitro after stimulation with serum treated zymosan (STZ) or IgG treated zymosan (IgTZ) was studied before and during therapy with penicillamine (n = 9) or sodium aurothiomalate (AuTM) (n = 12). Significant increases in rates of STZ (p less than 0.01) and IgTZ (p less than 0.02) stimulated superoxide anion production were seen after successful therapy (14 patients), which were paralleled by a significant increase in serum thiol levels. Patients who did not respond clinically to therapy (n = 4) showed a smaller mean increase in serum thiol levels and had high mean rates of in vitro superoxide production before and after second-line therapy. Three patients were withdrawn from the study. The data suggest that successful therapy with penicillamine or AuTM may be associated with monocyte activation, and possible mechanisms are discussed.

Full text

PDF
37

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. 1958 REVISION of diagnostic criteria for rheumatoid arthritis. Arthritis Rheum. 1959 Feb;2(1):16–20. doi: 10.1002/1529-0131(195902)2:1<16::aid-art1780020104>3.0.co;2-9. [DOI] [PubMed] [Google Scholar]
  2. Babior B. M. Oxygen-dependent microbial killing by phagocytes (second of two parts). N Engl J Med. 1978 Mar 30;298(13):721–725. doi: 10.1056/NEJM197803302981305. [DOI] [PubMed] [Google Scholar]
  3. Banford J. C., Brown D. H., Hazelton R. A., McNeil C. J., Sturrock R. D., Smith W. E. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis. Ann Rheum Dis. 1982 Oct;41(5):458–462. doi: 10.1136/ard.41.5.458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bonvini E., Bougnoux P., Stevenson H. C., Miller P., Hoffman T. Activation of the oxidative burst in human monocytes is associated with inhibition of methionine-dependent methylation of neutral lipids and phospholipids. J Clin Invest. 1984 Jun;73(6):1629–1637. doi: 10.1172/JCI111369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest Suppl. 1968;97:77–89. [PubMed] [Google Scholar]
  6. Carter S. D., Bourne J. T., Elson C. J., Hutton C. W., Czudek R., Dieppe P. A. Mononuclear phagocytes in rheumatoid arthritis: Fc-receptor expression by peripheral blood monocytes. Ann Rheum Dis. 1984 Jun;43(3):424–429. doi: 10.1136/ard.43.3.424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cleland L. G., Betts W. H., Vernon-Roberts B., Bielicki J. Role of iron and influence of antiinflammatory drugs on oxygen-derived free radical production and reactivity. J Rheumatol. 1982 Nov-Dec;9(6):885–892. [PubMed] [Google Scholar]
  8. Cohn Z. A. Activation of mononuclear phagocytes: fact, fancy, and future. J Immunol. 1978 Sep;121(3):813–816. [PubMed] [Google Scholar]
  9. Curnutte J. T., Babior B. M., Karnovsky M. L. Fluoride-mediated activation of the respiratory burst in human neutrophils. A reversible process. J Clin Invest. 1979 Apr;63(4):637–647. doi: 10.1172/JCI109346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Davis P., Johnston C., Miller C. L., Wong K. Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes. Arthritis Rheum. 1983 Jan;26(1):82–86. doi: 10.1002/art.1780260114. [DOI] [PubMed] [Google Scholar]
  11. Dawkins R. L., Zilko P. J., Carrano J., Garlepp M. J., McDonald B. L. Immunobiology of D-penicillamine. J Rheumatol Suppl. 1981 Jan-Feb;7:56–61. [PubMed] [Google Scholar]
  12. Ezekowitz R. A., Bampton M., Gordon S. Macrophage activation selectively enhances expression of Fc receptors for IgG2a. J Exp Med. 1983 Feb 1;157(2):807–812. doi: 10.1084/jem.157.2.807. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Goldstein I. M., Roos D., Kaplan H. B., Weissmann G. Complement and immunoglobulins stimulate superoxide production by human leukocytes independently of phagocytosis. J Clin Invest. 1975 Nov;56(5):1155–1163. doi: 10.1172/JCI108191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Goust J. M. Sodium periodate-induced human suppressor cells for polyclonal B cell activation. J Clin Lab Immunol. 1982 Sep;8(3):197–202. [PubMed] [Google Scholar]
  15. Greenwald R. A., Moy W. W. Inhibition of collagen gelation by action of the superoxide radical. Arthritis Rheum. 1979 Mar;22(3):251–259. doi: 10.1002/art.1780220307. [DOI] [PubMed] [Google Scholar]
  16. Hall N. D., Blake D. R., Bacon P. A. Serum sulphydryl levels in early synovitis. J Rheumatol. 1982 Jul-Aug;9(4):593–596. [PubMed] [Google Scholar]
  17. Herlin T., Borregaard N., Kragballe K. On the mechanism of enhanced monocyte and neutrophil cytotoxicity in severe psoriasis. J Invest Dermatol. 1982 Aug;79(2):104–108. doi: 10.1111/1523-1747.ep12500035. [DOI] [PubMed] [Google Scholar]
  18. Hirata F., Axelrod J. Phospholipid methylation and biological signal transmission. Science. 1980 Sep 5;209(4461):1082–1090. doi: 10.1126/science.6157192. [DOI] [PubMed] [Google Scholar]
  19. Hurst N. P., Bessac B., Nuki G. Monocyte superoxide anion production in rheumatoid arthritis: preliminary evidence for enhanced rates of superoxide anion production by monocytes from patients receiving penicillamine, sodium aurothiomalate and corticosteroids. Ann Rheum Dis. 1984 Feb;43(1):28–33. doi: 10.1136/ard.43.1.28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kitagawa S., Takaku F., Sakamoto S. A comparison of the superoxide-releasing response in human polymorphonuclear leukocytes and monocytes. J Immunol. 1980 Jul;125(1):359–364. [PubMed] [Google Scholar]
  21. Loos H., Blok-Schut B., Kipp B., van Doorn R., Meerhof L. Size distribution, electronic recognition, and counting of human blood monocytes. Blood. 1976 Nov;48(5):743–753. [PubMed] [Google Scholar]
  22. Lunec J., Halloran S. P., White A. G., Dormandy T. L. Free-radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol. 1981 Mar-Apr;8(2):233–245. [PubMed] [Google Scholar]
  23. McCord J. M. Free radicals and inflammation: protection of synovial fluid by superoxide dismutase. Science. 1974 Aug 9;185(4150):529–531. doi: 10.1126/science.185.4150.529. [DOI] [PubMed] [Google Scholar]
  24. McKeown M. J., Hall N. D., Corvalan J. R. Defective monocyte accessory function due to surface sulphydryl (SH) oxidation in rheumatoid arthritis. Clin Exp Immunol. 1984 Jun;56(3):607–613. [PMC free article] [PubMed] [Google Scholar]
  25. Metzger Z., Hoffeld J. T., Oppenheim J. J. Macrophage-mediated suppression. I. Evidence for participation of both hdyrogen peroxide and prostaglandins in suppression of murine lymphocyte proliferation. J Immunol. 1980 Feb;124(2):983–988. [PubMed] [Google Scholar]
  26. Murray H. W., Cohn Z. A. Macrophage oxygen-dependent antimicrobial activity. III. Enhanced oxidative metabolism as an expression of macrophage activation. J Exp Med. 1980 Dec 1;152(6):1596–1609. doi: 10.1084/jem.152.6.1596. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Novogrodsky A., Ravid A., Rubin A. L., Stenzel K. H. Hydroxyl radical scavengers inhibit lymphocyte mitogenesis. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1171–1174. doi: 10.1073/pnas.79.4.1171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Oyanagui Y. Inhibition of superoxide anion production in non-stimulated guinea pig peritoneal exudate cells by anti-inflammatory drugs. Biochem Pharmacol. 1978 Mar 1;27(5):777–782. doi: 10.1016/0006-2952(78)90520-8. [DOI] [PubMed] [Google Scholar]
  29. Panayi G. S. Does rheumatoid arthritis have a clinicopathological spectrum similar to that of leprosy? Ann Rheum Dis. 1982 Feb;41(1):102–103. doi: 10.1136/ard.41.1.102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Pick E., Mizel D. Role of transmethylation in the elicitation of an oxidative burst in macrophages. Cell Immunol. 1982 Sep 15;72(2):277–285. doi: 10.1016/0008-8749(82)90475-0. [DOI] [PubMed] [Google Scholar]
  31. Pike M. C., Snyderman R. Transmethylation reactions regulate affinity and functional activity of chemotactic factor receptors on macrophages. Cell. 1982 Jan;28(1):107–114. doi: 10.1016/0092-8674(82)90380-4. [DOI] [PubMed] [Google Scholar]
  32. Repine J. E., White J. G., Clawson C. C., Holmes B. M. The influence of phorbol myristate acetate on oxygen consumption by polymorphonuclear leukocytes. J Lab Clin Med. 1974 Jun;83(6):911–920. [PubMed] [Google Scholar]
  33. Simchowitz L., Mehta J., Spilberg I. Chemotactic factor-induced generation of superoxide radicals by human neutrophils: effect of metabolic inhibitors and antiinflammatory drugs. Arthritis Rheum. 1979 Jul;22(7):755–763. doi: 10.1002/art.1780220711. [DOI] [PubMed] [Google Scholar]
  34. Tsan M. F., Chen J. W. Oxidation of methionine by human polymorphonuclear leukocytes. J Clin Invest. 1980 May;65(5):1041–1050. doi: 10.1172/JCI109756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Walker L., Lowrie D. B. Killing of Mycobacterium microti by immunologically activated macrophages. Nature. 1981 Sep 3;293(5827):69–71. doi: 10.1038/293069a0. [DOI] [PubMed] [Google Scholar]
  36. Walker W. S. Mediation of macrophage cytolytic and phagocytic activities by antibodies of different classes and class-specific Fc-receptors. J Immunol. 1977 Aug;119(2):367–373. [PubMed] [Google Scholar]
  37. Waytz P. H., Douglas S. D. Increased antibody-dependent cell-mediated cytotoxicity by monocytes from patients with rheumatoid arthritis. Arthritis Rheum. 1979 May;22(5):490–494. doi: 10.1002/art.1780220508. [DOI] [PubMed] [Google Scholar]
  38. Weening R. S., Wever R., Roos D. Quantitative aspects of the production of superoxide radicals by phagocytizing human granulocytes. J Lab Clin Med. 1975 Feb;85(2):245–252. [PubMed] [Google Scholar]
  39. Yam L. T., Li C. Y., Crosby W. H. Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol. 1971 Mar;55(3):283–290. doi: 10.1093/ajcp/55.3.283. [DOI] [PubMed] [Google Scholar]
  40. van Furth R. The origin of phagocytic cells in the joint and bone. Scand J Rheumatol Suppl. 1981;40:13–20. doi: 10.3109/03009748109102871. [DOI] [PubMed] [Google Scholar]
  41. van GELDER B., SLATER E. C. The extinction coefficient of cytochrome c. Biochim Biophys Acta. 1962 Apr 23;58:593–595. doi: 10.1016/0006-3002(62)90073-2. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES